Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Letrozole in Lymphangioleiomyomatosis

NCT01353209 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT01353209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01353209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Letrozole in Lymphangioleiomyomatosis
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2014
Enrollment
17 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangioleiomyomatosis